Results 131 to 140 of about 5,020 (198)

Comparison of the enzymatic and cellular profiles of clinical JAK inhibitors for the treatment of myelofibrosis. [PDF]

open access: yesBlood Neoplasia
Celik H   +11 more
europepmc   +1 more source

Genetic Risk Factors and Clinical Implications of Glaucoma in the Saudi Population: A Review. [PDF]

open access: yesInt J Mol Sci
Alotaibi AF   +5 more
europepmc   +1 more source

Atypical Clinical Presentation and Diagnostic Difficulties of a Rare Disease: Fibrodysplasia Ossificans Progressiva. [PDF]

open access: yesPediatr Dermatol
Ouedraogo MS   +6 more
europepmc   +1 more source

The Role of ACVR1 in the Pathogenesis of Fibrodysplasia Ossificans Progressiva

open access: yes
Fibrodysplasia Ossificans Progressiva (FOP) is a rare and severely disabling genetic disorder characterized by progressive heterotopic ossification, where bone forms in soft tissues outside the normal skeletal structure.
BABU, S. R. (S)
core  

Recurrent evolution of ligand-binding domain multiplicity fine-tunes TGFβ signaling in vertebrates. [PDF]

open access: yesNat Commun
Jatzlau J   +13 more
europepmc   +1 more source

Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva. [PDF]

open access: yesPharmaceutics
Rosenberg NM   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy